Literature DB >> 23747510

Regulation of pathogenic Th17 cell differentiation by IL-10 in the development of glomerulonephritis.

Ruihua Zhang1, Qin Li, Peter Y Chuang, Geming Lu, Ruijie Liu, Jianjun Yang, Liang Peng, Yan Dai, Zihan Zheng, Chen-Feng Qi, John Cijiang He, Huabao Xiong.   

Abstract

Although it is clear that T helper (Th)17 cells play a pathologic role in the pathogenesis of several inflammatory diseases, the contribution and regulation of pathogenic Th17 cells in the development of glomerulonephritis are still not fully understood. Herein, we show that IL-10-deficient mice exhibit exacerbation of glomerulonephritis after induction with anti-glomerular basement membrane globulin, with enhanced pathogenic Th17 immune responses. We further demonstrate that Rag1(-/-) mice reconstituted with IL-10(-/-) CD4(+) T cells develop more severe glomerulonephritis after induction of anti-glomerular basement membrane disease, with more infiltration of inflammatory cells into the kidneys. Finally, IL-17 and interferon γ double-positive cells were significantly increased in IL-10(-/-) CD4(+) T-cell cultures under pathogenic Th17 conditions compared with wild-type cell cultures. These findings suggest that T-cell-derived IL-10 plays a critical suppressive role in the control of pathogenic Th17 cell differentiation and highlights the importance of IL-10 as protection against glomerulonephritis development.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23747510      PMCID: PMC3730759          DOI: 10.1016/j.ajpath.2013.05.001

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

1.  Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis.

Authors:  A R Kitching; P G Tipping; J R Timoshanko; S R Holdsworth
Journal:  Kidney Int       Date:  2000-02       Impact factor: 10.612

Review 2.  Glomerulonephritis.

Authors:  D E Hricik; M Chung-Park; J R Sedor
Journal:  N Engl J Med       Date:  1998-09-24       Impact factor: 91.245

Review 3.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

4.  Experimental autoimmune Goodpasture's disease: a pathogenetic role for both effector cells and antibody in injury.

Authors:  Elizabeth G Dean; Gabrielle R A Wilson; Ming Li; Kristy L Edgtton; Kim M O'Sullivan; Billy G Hudson; Stephen R Holdsworth; A Richard Kitching
Journal:  Kidney Int       Date:  2005-02       Impact factor: 10.612

5.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.

Authors:  Daniel J Cua; Jonathan Sherlock; Yi Chen; Craig A Murphy; Barbara Joyce; Brian Seymour; Linda Lucian; Wayne To; Sylvia Kwan; Tatyana Churakova; Sandra Zurawski; Maria Wiekowski; Sergio A Lira; Daniel Gorman; Robert A Kastelein; Jonathon D Sedgwick
Journal:  Nature       Date:  2003-02-13       Impact factor: 49.962

6.  Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer.

Authors:  Adel G A El-Shemi; Hidehiko Fujinaka; Asako Matsuki; Junichi Kamiie; Pavel Kovalenko; Zhenyun Qu; Vladimir Bilim; Goro Nishimoto; Eishin Yaoita; Yuatka Yoshida; Ignacio Anegon; Tadashi Yamamoto
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

7.  Interleukin-10 differentially modulates MHC class II expression by mesangial cells and macrophages in vitro and in vivo.

Authors:  S J Chadban; G H Tesch; R Foti; H Y Lan; R C Atkins; D J Nikolic-Paterson
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

8.  In situ upregulation of IL-10 reflects the activity of human glomerulonephritides.

Authors:  Z I Niemir; M Ondracek; G Dworacki; H Stein; R Waldherr; E Ritz; H F Otto
Journal:  Am J Kidney Dis       Date:  1998-07       Impact factor: 8.860

9.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

10.  Induction and molecular signature of pathogenic TH17 cells.

Authors:  Youjin Lee; Amit Awasthi; Nir Yosef; Francisco J Quintana; Sheng Xiao; Anneli Peters; Chuan Wu; Markus Kleinewietfeld; Sharon Kunder; David A Hafler; Raymond A Sobel; Aviv Regev; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2012-09-09       Impact factor: 25.606

View more
  5 in total

1.  Myeloid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization.

Authors:  Geming Lu; Ruihua Zhang; Shuo Geng; Liang Peng; Padmini Jayaraman; Chun Chen; Feifong Xu; Jianjun Yang; Qin Li; Hao Zheng; Kimberly Shen; Juan Wang; Xiyu Liu; Weidong Wang; Zihan Zheng; Chen-Feng Qi; Chuanping Si; John Cijiang He; Kebin Liu; Sergio A Lira; Andrew G Sikora; Liwu Li; Huabao Xiong
Journal:  Nat Commun       Date:  2015-03-27       Impact factor: 14.919

Review 2.  Regulation of iNOS on Immune Cells and Its Role in Diseases.

Authors:  Qingjie Xue; Yingchun Yan; Ruihua Zhang; Huabao Xiong
Journal:  Int J Mol Sci       Date:  2018-11-29       Impact factor: 5.923

3.  Antioxidative enzyme NAD(P)H quinone oxidoreductase 1 (NQO1) modulates the differentiation of Th17 cells by regulating ROS levels.

Authors:  Kyoko Nishida-Tamehiro; Akihiro Kimura; Takeshi Tsubata; Satoru Takahashi; Harumi Suzuki
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

Review 4.  Deeper insight into the role of IL-17 in the relationship beween hypertension and intestinal physiology.

Authors:  Ze-Jun Yang; Tian-Tian Wang; Bo-Ya Wang; Han Gao; Cheng-Wei He; Hong-Wei Shang; Xin Lu; Ying Wang; Jing-Dong Xu
Journal:  J Inflamm (Lond)       Date:  2022-10-04       Impact factor: 6.283

5.  Cytokine and Chemokine Expression in Kidneys during Chronic Leptospirosis in Reservoir and Susceptible Animal Models.

Authors:  Mariko Matsui; Louise Roche; Sophie Geroult; Marie-Estelle Soupé-Gilbert; Didier Monchy; Michel Huerre; Cyrille Goarant
Journal:  PLoS One       Date:  2016-05-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.